4//SEC Filing
CASTLIGHT HEALTH, INC. 4
Accession 0001140361-14-013535
CIK 0001433714operating
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:33 PM ET
Size
19.7 KB
Accession
0001140361-14-013535
Insider Transaction Report
Form 4
LAMONT ANN H
Director
Transactions
- Conversion
Series B Convertible Preferred Stock
2014-03-19−8,522,522→ 0 total(indirect: See footnote)Exercise: $0.00→ Class A Common Stock (8,522,522 underlying) - Conversion
Series A Convertible Preferred Stock
2014-03-19−814,884→ 0 total(indirect: See footnote)Exercise: $0.00→ Class A Common Stock (814,884 underlying) - Conversion
Series A-1 Convertible Preferred Stock
2014-03-19−653,582→ 0 total(indirect: See footnote)Exercise: $0.00→ Class A Common Stock (653,582 underlying) - Conversion
Series C Convertible Preferred Stock
2014-03-19−1,459,460→ 0 total(indirect: See footnote)Exercise: $0.00→ Class A Common Stock (1,459,460 underlying) - Conversion
Series D Convertible Preferred Stock
2014-03-19−345,064→ 0 total(indirect: See footnote)Exercise: $0.00→ Class A Common Stock (345,064 underlying) - Conversion
Class A Common Stock
2014-03-19+11,795,512→ 11,917,744 total(indirect: See footnote)Exercise: $0.00→ Class B Common Stock (11,795,512 underlying)
Footnotes (4)
- [F1]In connection with the consummation of the Issuer's initial public offering (the "IPO") on March 19, 2014, each share of Convertible Preferred Stock automatically converted into one (1) share of Class A Common Stock for no additional consideration. All shares of Class A Common Stock issued upon conversion were aggregated.
- [F2]Each share of Class A Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, that occurs after the closing of the IPO to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date.
- [F3]Each share of the Issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date.
- [F4]Represents securities directly owned by Oak Investment Partners XII, L.P and indirectly by Oak Associates XII, LLC, the sole general partner of Oak Investment Partners XII, L.P., and the Managing Members of Oak Associates XII, LLC. The "Managing Members" of Oak Associates XII, LLC are Ann H. Lamont, Bandel L. Carano, Edward F. Glassmeyer, Fredric W. Harman, Iftikar A. Ahmed, Grace A. Ames, Gerald R. Gallagher and Warren B. Riley. Such Managing Members have shared voting and investment control over all of the shares held by Oak Investment Partners XII, L.P.
Documents
Issuer
CASTLIGHT HEALTH, INC.
CIK 0001433714
Entity typeoperating
Related Parties
1- filerCIK 0001433714
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:33 PM ET
- Size
- 19.7 KB